<?xml version="1.0" encoding="UTF-8"?>
<dictionary title="VC_HemoMod_AggregatingAnti" version="0.0.1" encoding="UTF-8">
	<desc>Dictionary consisting of 1 terms plus 17 related synonyms. Some entries may also include the term's: source, description, wikidataID, chebiID, chebiName, FDAcode</desc>
	<author>Emanuel Faria, President of ®Verriclear Natural Skin Essentials Ltd. https://www.verriclear.com</author>
	<contributor>Peter Murray-Rust: Reader Emeritus in Molecular Informatics, Unilever Centre, Dept. Of Chemistry University of Cambridge</contributor>
	<disclaimer>This dictionary was manually collected, compiled and curated by the author. While every effort has been made to ensure the accuracy and completeness of the content of this dictionary, we do not guarantee its currency nor correctness. No warranty or fitness is provided or implied, and the author(s), contributor(s), partners, supporters, employees or associated organisations shall have neither liability nor responsibility to any person or entity with respect to any loss or damage arising from its use.</disclaimer>
	<license> This Work is licensed under Attribution-NonCommercial 4.0 International License © 2021 by Canilla Holdings Ltd. You are free to share (copy and redistribute the material in any medium or format) and/or adapt (remix, transform, and build upon the material) under the following terms: Attribution — You must give appropriate credit, provide a link to the license (https://creativecommons.org/licenses/by-nc/4.0/legalcode), and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything this license permits. </license>
	<entry term="platelet aggregation inhibitor agent" description="Use of a drug which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system." source=“="https://www.ebi.ac.uk/ols/ontologies/maxo" wikidataID="Q721432CHEBI:50427">
		<synonym>antiaggregant</synonym>
		<synonym>antiplatelet</synonym>
		<synonym>platelet aggregation factor inhibitor</synonym>
		<synonym>platelet aggregation inhibitor</synonym>
		<synonym>platelet aggregation inhibitor action</synonym>
		<synonym>platelet aggregation inhibitor activities</synonym>
		<synonym>platelet aggregation inhibitor activities treatment</synonym>
		<synonym>platelet aggregation inhibitor activity</synonym>
		<synonym>platelet aggregation inhibitor activity treatment</synonym>
		<synonym>platelet aggregation inhibitor agent treatment</synonym>
		<synonym>platelet aggregation inhibitor effect</synonym>
		<synonym>platelet aggregation inhibitor effects</synonym>
		<synonym>platelet aggregation inhibitor properties</synonym>
		<synonym>platelet aggregation inhibitor therapy</synonym>
		<synonym>treatment with platelet aggregation antagonist</synonym>
		<synonym>treatment with platelet aggregation blocker</synonym>
		<synonym>treatment with platelet aggregation inhibitor</synonym>
	</entry>
	<entry term="platelet-activating factor Inhibitor" description="A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system."  wikidataID="50427platelet aggregation inhibitor">
		<synonym>antiplatelet aggregation factor</synonym>
	</entry>
</dictionary>